← Back to Search

Group TMX (Telehealth Exercise and Mindfulness) for Osteoarthritis (TEMPO Trial)

N/A
Waitlist Available
Led By Deepak Kumar, PT, PhD
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Meet National Institute for Health and Clinical Excellence clinical guidelines for knee osteoarthritis (i.e., age ≥ 50 years, presence of activity related pain, presence of morning knee stiffness ≤ 30 minutes)
Knee pain on most days for 3 months or more
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through the recruitment process, up to 6 months from the start of the study
Awards & highlights

TEMPO Trial Summary

This trial compares using tech for mindful exercise with usual exercise for knee pain related to osteoarthritis.

Eligible Conditions
  • Osteoarthritis of the Knee

TEMPO Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are over 50 years old and have knee pain that worsens with activity, as well as stiffness in the morning that lasts no more than 30 minutes.
Select...
You have been experiencing knee pain for at least 3 months on most days.
Select...
You have experienced knee pain rated at 4 or higher out of 11 on a scale in the past week.

TEMPO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through the recruitment process, up to 6 months from the start of the study
This trial's timeline: 3 weeks for screening, Varies for treatment, and through the recruitment process, up to 6 months from the start of the study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attendance
Recruitment Rate
Retention Rate
Secondary outcome measures
6-minute walk test [OPTIONAL IN-PERSON VISIT]
7-meter walk test [OPTIONAL IN-PERSON VISIT]
Arthritis - Rapid Estimate of Adult Literacy in Medicine (A-REALM)
+33 more

TEMPO Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group TMX (Telehealth Exercise and Mindfulness)Experimental Treatment1 Intervention
Participants in this group will receive a supervised, group-based integrated mindfulness and exercise program once a week for 8 weeks via telehealth.
Group II: Group TX (Telehealth Exercise)Active Control1 Intervention
Participants in this group will receive a supervised and group-based exercise program once a week for 8 weeks via telehealth.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindful Exercise program
2022
N/A
~50

Find a Location

Who is running the clinical trial?

Boston University Charles River CampusLead Sponsor
113 Previous Clinical Trials
12,116 Total Patients Enrolled
3 Trials studying Osteoarthritis
222 Patients Enrolled for Osteoarthritis
Deepak Kumar, PT, PhDPrincipal InvestigatorBoston University
2 Previous Clinical Trials
122 Total Patients Enrolled
2 Trials studying Osteoarthritis
122 Patients Enrolled for Osteoarthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still available for this clinical trial?

"According to the listing on clinicaltrials.gov, this medical trial is actively searching for participants and has been since 10/4/2022. The post was most recently amended on 10/24/2022."

Answered by AI

What are the desired outcomes of this exploratory endeavor?

"The primary outcome for evaluation at the 12-week postintervention visit is patient Attendence. Secondary outcomes include Pain DETECT, a self-report measure with scores ranging from 0 to 5 that indicates higher gradations of pain (19 and above suggesting neuropathic pain), Arthritis - Rapid Estimate of Adult Literacy in Medicine (A-REALM) which is classified into 1 to 4 reading grade levels based on 66 word recognition adult health literacy test results, and Satisfaction Scale, a custom 4-item scale measuring satisfaction with intervention components scored between 0 and 10."

Answered by AI

How many people have enrolled in this clinical experiment?

"Indeed, the information on clinicaltrials.gov indicates that this trial is presently enlisting participants. It was originally posted on October 4th 2022 and last modified on October 24th 2022 with a requirement of 40 patients from 1 centre."

Answered by AI
~18 spots leftby Apr 2025